N
Novare Surgical
Novare Surgical Systems develops motion hand-held laparoscopic instruments to conduct minimally invasive surgeries
About Novare Surgical
Novare Surgical Systems, Inc. was a medical device company focused on the development and manufacturing of instruments for minimally invasive surgery (MIS). Founded in 1999 by Thomas J. Fogarty and Kerry Pope, the company was headquartered in Cupertino, California. Pope, who served as President and CEO until 2009, brought experience from roles at Baxter International and Computer Motion, Inc., a developer of robotic surgical systems. Fogarty was a notable figure in the medical field, known for inventing the Fogarty clamp.
The company's core business was manufacturing and supplying surgical equipment, including laparoscopic instruments, electrosurgical instruments, and surgical clamps. Initially, Novare Surgical focused on developing devices for cardiac surgery, building upon Fogarty's work on atraumatic occlusive clamps. A significant shift in focus occurred with the internal development of the RealHand technology platform, redirecting the company towards the broader minimally invasive surgery market. The business model centered on selling these specialized surgical instruments to healthcare facilities for use by surgeons in various procedures.
Novare Surgical's flagship product line was the RealHand High Dexterity (HD) instruments. These were among the first full-range-of-motion, hand-held laparoscopic instruments, designed to address the ergonomic and clinical challenges of MIS. The instruments utilized a proprietary EndoLink mechanism, which allowed the instrument's tip to mirror the surgeon's hand movements, providing tactile feedback and seven degrees of freedom without requiring additional hardware. This design enabled surgeons to perform complex maneuvers with greater control and dexterity, particularly in single-port laparoscopic surgeries where all instruments are inserted through a single incision, often in the patient's navel. The product range included graspers, dissectors, cautery tools, and needle holders, used in a wide array of procedures such as hysterectomies, gastric bypasses, and colectomies. The RealHand instruments received FDA 510(k) clearance and the CE mark, and were recognized with a 2008 Medical Design Excellence Award.
Throughout its operation, Novare Surgical raised a total of $32.3 million in funding over several rounds, including a $16 million Series D round in 2006 to commercialize the RealHand instruments. Key investors included Point Judith Capital, Tudor Investment Corp., Canaan Partners, and Deerfield Partners. Despite its product advancements and successful clinical applications, including enabling numerous 'first-ever' single-port procedures, the company eventually faced financial difficulties. In February 2011, Novare Surgical underwent liquidation. Following this, in February 2011, Vitalitec International, Inc. acquired the ENCLOSE II Anastomosis Assist Device from Novare.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES D✓Equity / VC | Oct 2006 | $16M | $64M | PJC · Tudor Investments | — |
| SERIES C✓Equity / VC | Jun 2002 | $9.8M | $39M | Canaan · Channel Medical Partners · Atherton Venture Partners · Three Arch Partners | — |
Growth signals
Latest recorded traffic for Novare Surgical is 0 monthly website visits. Novare Surgical's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
Temple TherapeuticsDeveloping innovative and clinically impactful therapies and diagnostics to improve quality of life |
Geleen, Netherlands | Operational | 8 | — | — |
FasciotensSurgical devices for abdominal wall closure |
Essen, Germany | Operational | |||
Centuri AnalyticsCenturi Analytics | Cinical Process Optimisation |
Dublin, Ireland | Operational | |||
iGEMBiotech & Life Sciences |
Cambridge, United States | Operational | |||
MOON FertilityBiotech & Life Sciences |
Göteborgs Stad, Sweden | Operational | |||
VAYU SenseIndustrial Internet of Things Solution for Bio-Pharma production |
Munich, Germany | Operational | |||
BfR ProfessionalBfR Professional aims to deliver relevant and interesting content about the new fitness and health trend |
Aarhus, Denmark | Operational | |||
Kaivogen OY (KAIV)Producer of high quality laboratory reagents |
Turku, Finland | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Novare Surgical in the Cupertino ecosystem
The Novare Surgical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later6 investors entered at this stage
- CPChannel Medical Partners
Canaan- APAtherton Venture Partners
Three Arch Partners
PJC
Tudor Investments
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Novare Surgical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Novare Surgical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







